Fertility Clinics & Infertility Services: $5.8 Billion United States Industry Analysis, 2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 30, 2018--The “U.S. Fertility Clinics & Infertility Services: An Industry Analysis” report has been added to ResearchAndMarkets.com’s offering.
This analysis by the publisher examines the controversial $5.8 billion infertility services/fertility clinics growth industry.
This loosely regulated baby business has weathered the last recession pretty well and has grown strongly since 2014, boosted both by demand domestically and via medical tourism patients from Europe and China. This largely untapped market is characterized by favorable demographics and a strong economy. Venture capital firms are eyeing the potential.
ART (assisted reproductive technology) now produces more than 50,000 babies per year in the U.S. via 263,000 IVF procedures, and demand is growing from the ranks of 7+ million infertile women, many of which delayed childbearing due to careers. Foreigners and gay couples are two other areas of growth.
There are about 480 U.S. fertility clinics, 100+ sperm banks, an unknown number of egg donors, and 1,700 reproductive endocrinologists competing for the business, which is lucrative. In addition, the global market for fertility drugs is just under $1 billion. Only one large chain, IntegraMed, exists, as most programs are run by small MD practices or are part of a hospital or University. The market is fragmented, served by mostly small regional clinics.
This 3rd edition study examines the nature/evolution of the business, national receipts/growth from 1988 to 2023 forecast, infertile customer demographics, key industry trends, industry regulation, pricing, industry consolidation, insurance coverage, ethical issues, and more.
Contains results of the latest (2015-2016) CDC ART survey national data, with IVF success rates and long-term trends, as well as European ART cycles survey data. The report also examines the nature/size of the U.S. sperm banks, egg donors, and fertility drugs markets, and surrogacy programs.
Competitor ProfilesCryos International California Cryobank Resolve Allan Guttmacher Institute Genetics and IVF Institute IntegraMed America
Key Topics Covered
2. Report Scope & Methodology, Sources used
3. Executive Overview of Major Findings
4. Nature & Structure of the Industry
5. Customer Demographics
6. Industry Size and Growth
7. Sperm Banks and Egg Donor Markets, Surrogacy
8. Egg Donor Market
9. Surrogacy Programs. Discussion of the need for it, mkt. size, fees, etc.
10. The Fertility Drugs Market
11. Findings of 2015-2016 CDC ART Surveys on Assisted Reproductive Technology - Success Rates
12. Major Competitor Profiles
For more information about this report visit https://www.researchandmarkets.com/research/mlrzd5/fertility_clinics?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181130005247/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Hospital Management,Women’s Health,Other Healthcare Facilities
KEYWORD: UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/30/2018 09:20 AM/DISC: 11/30/2018 09:20 AM